Assessing the role of minimally invasive radical hysterectomy for early-stage cervical cancer.


Journal

European journal of obstetrics, gynecology, and reproductive biology
ISSN: 1872-7654
Titre abrégé: Eur J Obstet Gynecol Reprod Biol
Pays: Ireland
ID NLM: 0375672

Informations de publication

Date de publication:
Aug 2022
Historique:
received: 08 04 2022
revised: 19 05 2022
accepted: 04 06 2022
pubmed: 27 6 2022
medline: 19 7 2022
entrez: 26 6 2022
Statut: ppublish

Résumé

Surgery is the mainstay of treatment in the management of early-stage cervical cancer. Until the publication of the Laparoscopic Approach to Cervical Cancer (LACC) trial, minimally invasive radical hysterectomy was the recommended approach to treat patients with early-stage disease. The results of the LACC trial questioned the adoption of minimally invasive surgery in cervical cancer. In comparison with the open approach, minimally invasive surgery correlated with worse disease-free and cancer-specific survival. Similarly, other retrospective studies highlighted this correlation, thus corroborating the results of the LACC trials. In the present review, we evaluated current evidence and further prospective of the adoption of minimally invasive radical hysterectomy in cervical cancer. Moreover, we sought to assess some unsolved issues regarding the role of minimally invasive surgery in early-stage cervical cancer patients.

Identifiants

pubmed: 35753229
pii: S0301-2115(22)00379-7
doi: 10.1016/j.ejogrb.2022.06.004
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

64-69

Commentaires et corrections

Type : ErratumIn

Informations de copyright

Copyright © 2022. Published by Elsevier B.V.

Auteurs

Giorgio Bogani (G)

Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.

Violante Di Donato (V)

Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy. Electronic address: violante.didonato@uniroma1.it.

Ludovico Muzii (L)

Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.

Jvan Casarin (J)

Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Varese, Italy.

Fabio Ghezzi (F)

Department of Obstetrics and Gynecology, 'Filippo Del Ponte' Hospital, University of Insubria, Varese, Italy.

Mario Malzoni (M)

Endoscopica Malzoni, Center for Advanced Endoscopic Gynecological Surgery, Avellino, Italy.

Stefano Greggi (S)

Gynecology Oncology Unit, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.

Fabio Landoni (F)

Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.

Luca Bazzurini (L)

Gynecology Oncology Surgical Unit, Department of Obstetrics and Gynecology, San Gerardo Hospital, University of Milano-Bicocca, Monza, Italy.

Vanna Zanagnolo (V)

Gynecology Oncology Unit, Istituto Europeo di Oncologia, Milano, Italy.

Francesco Multinu (F)

Gynecology Oncology Unit, Istituto Europeo di Oncologia, Milano, Italy.

Roberto Angioli (R)

Campus Bio-Medico University of Rome, Italy.

Francesco Plotti (F)

Campus Bio-Medico University of Rome, Italy.

Giuseppe Caruso (G)

Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.

Margherita Fischetti (M)

Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.

Gabriella Ferrandina (G)

UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy.

Innocenza Palaia (I)

Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.

Pierluigi Benedetti Panici (P)

Department of Gynecological, Obstetrical and Urological Sciences, "Sapienza" University of Rome, Italy.

Giovanni Scambia (G)

UOC Ginecologia Oncologica, Dipartimento per la salute della Donna e del Bambino e della Salute Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Roma, Italy.

Francesco Raspagliesi (F)

Gynecological Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH